Sunbird Bio is enabling precision neurology through the development of SunbirdDx, a comprehensive blood-based diagnostic platform designed to support earlier, more accurate diagnosis and treatment of Alzheimer’s disease, Parkinson’s disease and other neurological disorders. SunbirdDx is the first platform that has demonstrated the ability to directly detect and quantify the disease-specific proteins that aggregate in the brain and signal the presence of neurological disorders as well as co-pathologies that may be present. These proteins include alpha synuclein (α-synuclein), TDP-43, amyloid beta (Aβ), tau, and other protein and non-protein biomarkers.
| Website | https://www.sunbirdbio.com/ |
| Employees | 18 (9 on RocketReach) |
| Founded | 2021 |
| Address | 35 Cambridgepark Dr Suite 100, Cambridge, Massachusetts 02140, US |
| Industry | Biotechnology Research |
| Keywords | Alzheimers Diagnosis, Diagnostic Tests, Protein Detection, Protein Aggregation, Biomarkers, Disease Diagnostics, Protein Analysis, Diagnostic Tools, Neurological Diagnostics, Alzheimers Research, Early Detection, Medical Diagnostics, In-Vitro Diagnostics, Precision Diagnostics, Clinical Diagnostics, Molecular Diagnostics, Biotechnology, Life Sciences |
| Competitors | Amgen, Regeneron, Sarepta Therapeutics, Inc., Vertex Pharmaceuticals, Biogen, Novartis, Gilead Sciences, AstraZeneca, Pfizer, Johnson & Johnson +45 more (view full list) |
Looking for a particular Sunbird Bio employee's phone or email?
Richard Batrla is the Chief Medical Officer of Sunbird Bio.
9 people are employed at Sunbird Bio.
Sunbird Bio is based in Cambridge, Massachusetts.